Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Neuro-Degenerative Diseases|March 13, 2010
Filamentous phages reduce alpha-synuclein oligomerization in the membrane fraction of SH-SY5Y cellsHemi Dimant, Beka SolomonBiochemical and Biophysical Research Communications|April 22, 2009
Modulation effect of filamentous phage on alpha-synuclein aggregationHemi Dimant, Noa Sharon, Beka SolomonThe Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry|July 26, 2012
Molecular chaperones and co-chaperones in Parkinson diseaseHemi Dimant, Darius Ebrahimi-Fakhari, Pamela J McLeanJournal of Immunotherapy (Hagerstown, Md. : 1997)|February 9, 2010
TAR1, a human anti-p53 single-chain antibody, restores tumor suppressor function to mutant p53 variantsSara Orgad, Hemi Dimant, Eyal Dor-On, et al.Plos One|March 26, 2014
Direct visualization of CHIP-mediated degradation of alpha-synuclein in vivo: implications for PD therapeuticsHemi Dimant, Liya Zhu, Laura N Kibuuka, et al.Molecular Imaging and Biology|July 18, 2024
Cryo-Fluorescence Tomography as a Tool for Visualizing Whole-Body Inflammation Using Perfluorocarbon Nanoemulsion TracersBenjamin I Leach, Deanne Lister, Stephen R Adams, et al.Acta Neuropathologica Communications|November 21, 2013
Direct detection of alpha synuclein oligomers in vivoHemi Dimant, Suneil K Kalia, Lorraine V Kalia, et al.Plos One|January 28, 2014
Chronic treatment with novel small molecule Hsp90 inhibitors rescues striatal dopamine levels but not α-synuclein-induced neuronal cell lossNikolaus R McFarland, Hemi Dimant, Laura Kibuuka, et al.JCI Insight|October 18, 2019
Brain pharmacology of intrathecal antisense oligonucleotides revealed through multimodal imagingCurt Mazur, Berit Powers, Kenneth Zasadny, et al.Journal of Virology|October 16, 2023
Characterization and biodistribution of under-employed gene therapy vector AAV7Samantha A Yost, Emre Firlar, Justin D Glenn, et al.Pageof 1